Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Carcinoma, Hepatocellular | 7 | 2019 | 1222 | 1.66 | Why? |
| Liver Neoplasms | 7 | 2019 | 1666 | 1.45 | Why? |
| Hepatitis C, Chronic | 4 | 2019 | 973 | 0.94 | Why? |
| Neoplasm Recurrence, Local | 2 | 2018 | 1063 | 0.86 | Why? |
| Frontal Lobe | 2 | 2020 | 191 | 0.79 | Why? |
| Serpins | 1 | 2017 | 67 | 0.68 | Why? |
| Hepatitis C Antibodies | 1 | 2017 | 120 | 0.64 | Why? |
| Antigens, Neoplasm | 1 | 2017 | 230 | 0.59 | Why? |
| Brain Diseases | 3 | 2021 | 1463 | 0.55 | Why? |
| Hodgkin Disease | 1 | 2017 | 204 | 0.54 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2017 | 403 | 0.51 | Why? |
| Virus Activation | 1 | 2017 | 480 | 0.47 | Why? |
| Hepatitis B | 2 | 2017 | 888 | 0.46 | Why? |
| Hepacivirus | 2 | 2018 | 1509 | 0.43 | Why? |
| Ischemic Attack, Transient | 3 | 2020 | 439 | 0.40 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.39 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.37 | Why? |
| Sustained Virologic Response | 3 | 2019 | 378 | 0.36 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.35 | Why? |
| Neoplasm Staging | 4 | 2018 | 1999 | 0.34 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.29 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.28 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.28 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.26 | Why? |
| Parkinson Disease | 3 | 2020 | 1414 | 0.23 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.21 | Why? |
| Liver | 3 | 2021 | 4007 | 0.21 | Why? |
| Ambrosia | 1 | 2019 | 4 | 0.20 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.20 | Why? |
| Coitus | 1 | 2020 | 44 | 0.20 | Why? |
| Quantitative Trait, Heritable | 1 | 2019 | 26 | 0.20 | Why? |
| Antiviral Agents | 5 | 2019 | 41703 | 0.20 | Why? |
| Encephalopathy, Bovine Spongiform | 1 | 2018 | 7 | 0.20 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.20 | Why? |
| Hospital Rapid Response Team | 1 | 2020 | 100 | 0.19 | Why? |
| Parkinsonian Disorders | 1 | 2020 | 118 | 0.19 | Why? |
| Creutzfeldt-Jakob Syndrome | 1 | 2018 | 35 | 0.19 | Why? |
| Liver Cirrhosis | 3 | 2019 | 1810 | 0.18 | Why? |
| Pollen | 1 | 2019 | 137 | 0.18 | Why? |
| Survival | 1 | 2018 | 53 | 0.18 | Why? |
| Supranuclear Palsy, Progressive | 1 | 2017 | 20 | 0.17 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.17 | Why? |
| Cerebral Cortex | 2 | 2017 | 276 | 0.17 | Why? |
| Amnesia, Transient Global | 1 | 2016 | 13 | 0.17 | Why? |
| Intracranial Arteriosclerosis | 1 | 2017 | 46 | 0.17 | Why? |
| Elasticity Imaging Techniques | 1 | 2019 | 194 | 0.16 | Why? |
| Multiple System Atrophy | 1 | 2017 | 66 | 0.16 | Why? |
| Heart Aneurysm | 1 | 2017 | 46 | 0.16 | Why? |
| Immunotherapy, Adoptive | 1 | 2021 | 524 | 0.15 | Why? |
| Facial Recognition | 1 | 2017 | 75 | 0.15 | Why? |
| Hippocampus | 1 | 2016 | 237 | 0.14 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2017 | 219 | 0.14 | Why? |
| Thrombin | 1 | 2017 | 325 | 0.13 | Why? |
| Heart Atria | 1 | 2017 | 267 | 0.13 | Why? |
| White Matter | 1 | 2017 | 369 | 0.13 | Why? |
| Magnetic Resonance Imaging | 3 | 2020 | 6551 | 0.13 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Electroencephalography | 1 | 2020 | 1242 | 0.12 | Why? |
| Italy | 6 | 2020 | 38444 | 0.12 | Why? |
| Multivariate Analysis | 3 | 2019 | 5440 | 0.12 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.12 | Why? |
| Metabolic Diseases | 1 | 2018 | 505 | 0.12 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.12 | Why? |
| Disease Progression | 3 | 2018 | 13580 | 0.11 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.09 | Why? |
| Social Class | 1 | 2017 | 1360 | 0.09 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.09 | Why? |
| Humans | 26 | 2021 | 930598 | 0.08 | Why? |
| Brain | 2 | 2021 | 5133 | 0.08 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.07 | Why? |
| Female | 15 | 2020 | 380317 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Emotions | 1 | 2017 | 2418 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.05 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.05 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.05 | Why? |
| Middle Aged | 11 | 2020 | 270681 | 0.05 | Why? |
| Germination | 1 | 2019 | 8 | 0.05 | Why? |
| Elastic Modulus | 1 | 2019 | 22 | 0.05 | Why? |
| Plant Development | 1 | 2019 | 29 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Rutin | 1 | 2019 | 44 | 0.05 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.05 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
| Risk Factors | 5 | 2019 | 71621 | 0.05 | Why? |
| Seeds | 1 | 2019 | 114 | 0.05 | Why? |
| Adult | 6 | 2020 | 244371 | 0.05 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Pleasure | 1 | 2017 | 10 | 0.04 | Why? |
| Adipokines | 1 | 2018 | 87 | 0.04 | Why? |
| Verbal Learning | 1 | 2016 | 15 | 0.04 | Why? |
| Photic Stimulation | 1 | 2017 | 74 | 0.04 | Why? |
| Basal Ganglia | 1 | 2017 | 49 | 0.04 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.04 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.04 | Why? |
| Pattern Recognition, Visual | 1 | 2017 | 32 | 0.04 | Why? |
| Linguistics | 1 | 2017 | 50 | 0.04 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.04 | Why? |
| Facial Expression | 1 | 2017 | 74 | 0.04 | Why? |
| Mouth Mucosa | 1 | 2020 | 323 | 0.04 | Why? |
| Prednisone | 1 | 2021 | 652 | 0.04 | Why? |
| Thrombomodulin | 1 | 2017 | 121 | 0.04 | Why? |
| Protein C | 1 | 2017 | 141 | 0.04 | Why? |
| Hepatitis B Antibodies | 1 | 2017 | 142 | 0.04 | Why? |
| Happiness | 1 | 2017 | 111 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2019 | 557 | 0.04 | Why? |
| North America | 1 | 2020 | 1400 | 0.04 | Why? |
| Central Nervous System | 1 | 2021 | 701 | 0.04 | Why? |
| Hepatitis B Surface Antigens | 1 | 2017 | 305 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Flavonoids | 1 | 2019 | 492 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| New Zealand | 1 | 2020 | 2073 | 0.03 | Why? |
| Stroke | 1 | 2016 | 8839 | 0.03 | Why? |
| Social Perception | 1 | 2017 | 371 | 0.03 | Why? |
| Allergens | 1 | 2019 | 728 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Poverty Areas | 1 | 2017 | 556 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2020 | 1044 | 0.03 | Why? |
| Blood Coagulation Tests | 1 | 2017 | 855 | 0.03 | Why? |
| Cognition | 1 | 2021 | 1394 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2016 | 954 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Frail Elderly | 1 | 2020 | 1427 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Australia | 1 | 2020 | 6306 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.02 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.02 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Cities | 1 | 2017 | 4937 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Protein Binding | 1 | 2019 | 11430 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
Guarino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(161)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_